Wearable AI Novosound is advancing ultrasound wearables with a lightweight, miniaturized sensor platform and accuracy comparable to cuff-based devices, presenting a clear sales angle for medical device integration, wearables partnerships, and clinical validation opportunities.

Medical Expansion Executive leadership focus in medical technology and a recent appointment in Scotland signals a strategic push into medical markets, suggesting opportunities for multi-country distribution, clinical collaborations, and hospital system pilots.

Healthcare Partnerships Active collaborations with Texas Medical Center and demonstrations at CES indicate a strong channel for academic and clinical partnerships, enabling co-development, pilots, and exposure to large healthcare networks.

Funding & Growth Recent funding rounds totaling around 15 million and headcount growth to 42+ position Novosound for scale in sales, marketing, and regional deployments, supporting capacity for enterprise deals and larger contract opportunities.

Strategic Location Glasgow-based headquarters with a BioCity expansion provides a credible regional hub for EMEA sales, regulatory engagement, and partner ecosystems, enabling localized support and faster time-to-value for Europe-focused opportunities.